5 randomised controlled trials (RCTs) were included in the review.
RCTs were analysed using the CONSORT guidelines and the Cochrane risk of bias tool.
Growth factors combined with beta-tricalcium phosphate (β-TCP) improved all outcomes.
β-TCP alone resulted in less improved clinical and radiographic outcomes.
Only a difference in gingival recession was observed between different growth factors.